These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11461085)

  • 1. Impaired FHIT expression characterizes serous ovarian carcinoma.
    Ozaki K; Enomoto T; Yoshino K; Fujita M; Buzard GS; Kawano K; Yamasaki M; Murata Y
    Br J Cancer; 2001 Jul; 85(2):247-54. PubMed ID: 11461085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. fhit Alterations in endometrial carcinoma and hyperplasia.
    Ozaki K; Enomoto T; Yoshino K; Hongbo S; Nakamura T; Fujita M; Kuragaki C; Sakata M; Kurachi H; Murata Y
    Int J Cancer; 2000 Feb; 85(3):306-12. PubMed ID: 10652418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas].
    Hong FZ; Wang B; Li HM; Liew CT
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):257-61. PubMed ID: 16181544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of abnormal transcripts of the FHIT (fragile histidine triad) gene in ovarian carcinoma.
    Mandai M; Konishi I; Kuroda H; Nanbu K; Matsushita K; Yura Y; Hamid AA; Mori T
    Eur J Cancer; 1998 Apr; 34(5):745-9. PubMed ID: 9713284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
    Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
    Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FHIT gene in oral squamous cell carcinoma: allelic imbalance is frequent but cDNA aberrations are uncommon.
    Pateromichelakis S; Lee G; Langdon JD; Partridge M
    Oral Oncol; 2000 Mar; 36(2):180-8. PubMed ID: 10745170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites.
    Manning AP; Mes-Masson AM; Seymour RJ; Tetrault M; Provencher DM; Tonin PN
    Mol Carcinog; 1999 Mar; 24(3):218-25. PubMed ID: 10204806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines.
    Hendricks DT; Taylor R; Reed M; Birrer MJ
    Cancer Res; 1997 Jun; 57(11):2112-5. PubMed ID: 9187105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of FHIT expression in gastric carcinoma.
    Baffa R; Veronese ML; Santoro R; Mandes B; Palazzo JP; Rugge M; Santoro E; Croce CM; Huebner K
    Cancer Res; 1998 Oct; 58(20):4708-14. PubMed ID: 9788626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
    Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ
    Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas.
    Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH
    Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHIT gene abnormalities in both benign and malignant thyroid tumours.
    Zou M; Shi Y; Farid NR; al-Sedairy ST; Paterson MC
    Eur J Cancer; 1999 Mar; 35(3):467-72. PubMed ID: 10448301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of FHIT gene alterations in ovarian cancer.
    Buttitta F; Marchetti A; Radi O; Bertacca G; Pellegrini S; Gadducci A; Genazzani AR; Bevilacqua G
    Br J Cancer; 1998 Apr; 77(7):1048-51. PubMed ID: 9569038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FHIT (fragile histidine triad) gene analysis in cervical intraepithelial neoplasia.
    Liu FS; Hsieh YT; Chen JT; Ho ES; Hung MJ; Lin AJ
    Gynecol Oncol; 2001 Aug; 82(2):283-90. PubMed ID: 11531281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
    Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
    Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.